What we have done so far

Innovative therapies for skin diseases

Maximising the value of your assets for patients suffering from a dermatological condition

Our Aim

We are looking for partnering opportunities on new assets (small molecules, biologics, or advanced therapies) in clinical or preclinical development stages that could be used for the treatment of dermatological conditions.

Preferably, the assets should target immuno-inflammatory pathways with rationale for dermatological indications, such as atopic dermatitis, hidradenitis suppurativa, alopecia areata, and vitiligo, or be suitable for non-melanoma skin cancer, or rare dermatological indications.

Our interest

New assets in clinical or preclinical development stages

What we offer

Access to our expertise in dermatological R&D

Your benefit

A partnership opportunity

Shared goal

Finding innovative therapies for patients

Call Results